化学
去唾液酸糖蛋白受体
肝细胞癌
铜
癌症研究
细胞凋亡
螯合作用
氨基脲
肝细胞
生物化学
体外
立体化学
无机化学
生物
有机化学
作者
Xueke Zhao,Xiang Li,Xiaoping Huang,Shuyu Liang,Penggen Cai,Yuhui Wang,Yongming Cui,Chen Wu,Xiongwei Dong
标识
DOI:10.1016/j.arabjc.2021.103241
摘要
Hepatic copper deposition leads to metabolic disorders, rapid increase in reactive oxygen species (ROS) levels, and even the occurrence and metastasis of hepatocellular carcinoma. Copper chelation or copper transporter inhibition have already been developed into an effective method to control the canceration of hepatocytes and kill the hepatocarcinoma cells. Here, we designed three novel lactobionic acid conjugated copper chelators (GT1, 9 and 10), which have the potential to be recognized by asialoglycoprotein receptor (ASGPR), a high-capacity C-type lectin receptor selectively expressed in liver. Both GT1, 9 and 10 can selectively and efficiently coordinate with copper in solution and in the high-copper treated hepatocellular carcinomas model (HC HepG2 cells). The thiosemicarbazone-based chelator GT1 should more effectively eliminate copper and promote apoptosis of HC HepG2 cells, which might have application prospects in preventing cancerization and other pathological lesions caused by copper deposition of liver. Moreover, our results also revealed the potential of GT1 to be harnessed as preventive leading structures of the hepatocellular carcinomas.
科研通智能强力驱动
Strongly Powered by AbleSci AI